Prosecution Insights
Last updated: August 17, 2026

Examiner: TOMBERS, JOSEPH A

Tech Center 3700 • Art Units: 3783 3791

This examiner grants 48% of resolved cases

Performance Statistics

48.0%
Allow Rate
-22.0% vs TC avg
252
Total Applications
+30.6%
Interview Lift
1426
Avg Prosecution Days
Based on 200 resolved cases, 2023–2026

Rejection Statute Breakdown

8.5%
§101 Eligibility
25.1%
§102 Novelty
47.4%
§103 Obviousness
18.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17889779 ELECTRONIC DEVICE WITH SENSOR AND METHOD OF OPERATING THE SAME Non-Final OA Samsung Electronics Co., Ltd.
18896231 MULTIPLE DEVICE CONNECTIVITY FOR HEALTH SENSOR Non-Final OA Abbott Diabetes Care Inc.
18838806 SYSTEMS, DEVICES, AND METHODS FOR AN ANALYTE SENSOR Non-Final OA ABBOTT DIABETES CARE INC.
18639650 INCORPORATION OF SILVER SALTS WITHIN A TRANSCUTANEOUS BIOSENSOR FOR INFECTION CONTROL Final Rejection Abbott Diabetes Care Inc.
18573155 PATIENT SUPPORT APPARATUSES WITH PATIENT MONITORING Final Rejection Stryker Corporation
17273618 SYSTEM FOR DETERMINING A BLOOD PRESSURE OF ONE OR A PLURALITY OF USERS Non-Final OA AKTIIA SA
18536619 ELONGATE MEMBER WITH COUPLER TO PROVIDE RADIAL TRANSITION OF TRANSLATING MEMBER Final Rejection Auris Health, Inc.
18804611 INTRA-BEAT BIOMARKER FOR ACCURATE BLOOD PRESSURE ESTIMATIONS Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
17481612 OPHTHALMOLOGIC APPARATUS Non-Final OA TOPCON CORPORATION
18494304 SYSTEMS, APPARATUSES, AND METHODS FOR DETECTING AIR BREATHED BY A USER Non-Final OA Honeywell Safety Products USA, Inc.
18573484 Capillary Blood Collection Device Final Rejection Becton, Dickinson and Company
18573040 Capillary Blood Collection Device Final Rejection Becton, Dickinson and Company

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month